The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
研究概览
简要总结
This study uses serum tissue factor and tissue factor inhibitor and factor VII to monitor the pre-coagulation status in lung cancer patients and to correlate the pre-coagulation status with clinical staging and prognosis.
详细描述
The staging of lung cancer was according to tumor size, involvement of lymph node and metastatic status. But there is a different prognosis in cancer patients of the same stage. The coagulation status of cancer patients was considered as an important possible prognostic factor. So in this study, we want to evaluate patients' coagulation status and find the relation of coagulation status and cancer status.
We thus propose a prospective study using coagulation factors in order to search for the relationship between cancer stage and pre-coagulation status in Taiwanese lung cancer patients. We will also evaluate the potential use of tissue factor as a prognosis predictor in lung cancer patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Natural History
- 时间视角
- Other
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with newly-diagnosed lung cancer
- •Serum from cancer-free healthy volunteers
排除标准
- •Chronic renal failure or end-stage renal disease [ESRD] (creatinine [Cr] > 2 )
- •Hyperlipidemia on statin therapy
- •Acute myocardial infarction
- •Tapal or Plavix use
- •Active thromboembolic event
- •Severe liver disease (> child B)